New antibodies in the area of peptide hormones and infectious diseases
Submission of a registration application to the FDA, for approval of The NGAL Test™
New antibodies in the area of complement and infectious diseases
NGAL ELISA Kit 036
These Terms and Conditions (“Terms") governing the sale of products and related services ("Products”) from BioPorto Diagnostics A/S ("BIOPORTO") and Buyer. Any deviating conditions or reservations by Buyer shall only be binding if confirmed in writing by BIOPORTO. Conditions are also applicable in individual cases where Terms are not attached, but which Buyer has been made aware of the Terms.